Market Value1,712,054,000
Total Holdings70
File Date2022-02-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
RETA / Reata Pharmaceuticals Inc - Class A
CTIC / CTI BioPharma Corp
ALXO / ALX Oncology Holdings Inc.
KDMN / Kadmon Holdings Inc
HZNP / Horizon Therapeutics Plc
CLDX / Celldex Therapeutics, Inc.
ICPT / Intercept Pharmaceuticals Inc Call
TVTX / Travere Therapeutics, Inc.
XNCR / Xencor, Inc.
XLRN / Acceleron Pharma Inc
JNCE / Jounce Therapeutics Inc
ALGN / Align Technology, Inc.
INZY / Inozyme Pharma, Inc.
UTHR / United Therapeutics Corporation
SNDX / Syndax Pharmaceuticals, Inc.
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
ABBV / AbbVie Inc.
VIR / Vir Biotechnology, Inc. Put
KURA / Kura Oncology, Inc.
CYT / Cyteir Therapeutics, Inc.
ZYME / Zymeworks Inc.
OBSV / ObsEva SA.
ALGS / Aligos Therapeutics, Inc.
BPMC / Blueprint Medicines Corporation
BMY / Bristol-Myers Squibb Company Call
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
EW / Edwards Lifesciences Corporation
PODD / Insulet Corporation
PDSB / PDS Biotechnology Corporation
IFRX / InflaRx N.V.
AKUS / Akouos Inc
SRRA / Sierra Oncology Inc
ZTS / Zoetis Inc.
RGNX / REGENXBIO Inc.
PTCT / PTC Therapeutics, Inc.
RHHBY / Roche Holding AG - Depositary Receipt (Common Stock)
GH / Guardant Health, Inc.
FUSN / Fusion Pharmaceuticals Inc.
INBX.V / Inhibrx, Inc.
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
CMPI / Checkmate Pharmaceuticals Inc
BMRN / BioMarin Pharmaceutical Inc.
INKT / MiNK Therapeutics, Inc.
REGN / Regeneron Pharmaceuticals, Inc. Put
IWM / iShares Trust - iShares Russell 2000 ETF Put
CCXI / ChemoCentryx Inc
CCXI / ChemoCentryx Inc Put
UTHR / United Therapeutics Corporation Put
ITCI / Intra-Cellular Therapies, Inc.
IRTC / iRhythm Technologies, Inc.
QQQ / Invesco QQQ Trust, Series 1 Put
HRTX / Heron Therapeutics, Inc.
GRTX / Galera Therapeutics, Inc.
ISEE / IVERIC bio Inc Put
PTGX / Protagonist Therapeutics, Inc.
PTGX / Protagonist Therapeutics, Inc. Call
BIIB / Biogen Inc.
ISEE / IVERIC bio Inc
CYTK / Cytokinetics, Incorporated
FULC / Fulcrum Therapeutics, Inc.
14161H108 / Cardtronics PLC
AXSM / Axsome Therapeutics, Inc. Put
VERA / Vera Therapeutics, Inc.
IMTX / Immatics N.V.
EXEL / Exelixis, Inc.
MRTX / Mirati Therapeutics, Inc.
ACET / Adicet Bio, Inc.
BCRX / BioCryst Pharmaceuticals, Inc.
AVTE / Aerovate Therapeutics, Inc.
NCNA / NuCana plc - Depositary Receipt (Common Stock)
YMAB / Y-mAbs Therapeutics, Inc.
NVCR / NovoCure Limited Call
MRK / Merck & Co., Inc. Call
KRTX / Karuna Therapeutics, Inc.
IMGN / ImmunoGen, Inc.
SPY / SPDR S&P 500 ETF Put
SYBX / Synlogic, Inc.
NXTC / NextCure, Inc.
KURA / Kura Oncology, Inc. Call
DXCM / DexCom, Inc.
QURE / uniQure N.V.
NTRA / Natera, Inc.
SRPT / Sarepta Therapeutics, Inc.
INSM / Insmed Incorporated
AGEN / Agenus Inc.
BOLT / Bolt Biotherapeutics, Inc.
MRNS / Marinus Pharmaceuticals, Inc.